Navigation Links
Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301)
Date:9/29/2011

ter understand the mechanisms of this activity and identify the characteristics of children most likely to respond."

Dr. Hans Loibner, CEO of Apeiron: "We are proud to collaborate with this renowned co-operative group. COG's expertise and the quality of their clinical network in the U.S. and Canada are most impressive. The study will give important insights into the efficacy of APN301 in high-risk neuroblastoma patients and the results may serve as an important component for the registration of this innovative immunotherapy."


*Original Publication: Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study. Suzanne S. Shusterman, Wendy B. London, Stephen D. Gillies, Jacquelyn A. Hank, Stephan D. Voss, Robert C. Seeger, C. Patrick Reynolds, Jennifer Kimball, Mark R. Albertini, Barrett Wagner, Jacek Gan, Jens Eickhoff, Kenneth B. DeSantes, Susan L. Cohn, Toby Hecht, Brian Gadbaw, Ralph A. Reisfeld, John M. Maris, and Paul M. Sondel. Journal of Clinical Oncology (2010) 28: 4969-4975.

About The Children's Oncology Group:

The Children's Oncology Group (childrensoncologygroup.org), a National Cancer Institute supported clinical trials group, is the world's largest organization devoted exclusively to childhood and adolescent cancer research. The Children's Oncology Group (COG) unites more than 7.500 experts in childhood cancer at more than 200 leading children's hospitals, universities, and cancer centers across North America, Australia, New Zealand, and Europe in the fight against childhood cancer. COG research has turned children's cancer from a virtually incurable disease 50 years ago into one with an overall cure rate approaching 80 percent today. Research conducted by the COG is also supported through the generosity of individuals, corporations and private foundations working with The Children's Oncology Group Foundation (TheCOGFoundation.org), which enables p
'/>"/>

SOURCE APEIRON Biologics AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. XECAN and Trimble Partner to Deliver ThingMagic Powered RFID Oncology Solution
2. Champions Oncology Clarifies Misstatements in News Article
3. Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar
4. Champions Oncology Reports Full Year 2011 Financial Results
5. McKesson Specialty Care Solutions
6. US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work
7. Genentech and Novartis Remain Image Leaders in Oncology and Hematology
8. Oncology National Commercial (ONC) Study Outlines 10 Trends Shaping the Market for Oncology Pharmaceutical and Biotech Products
9. Reportlinker Adds Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
10. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
11. Beardsworth Continues to Strengthen Oncology Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... years. And according to My Cleaning Products, many turn to ... However, because of the health and environmental risks those solutions ... bugs with Bed Bug Bully instead. , According ... on bed bugs as they used to be. It shared ...
(Date:5/21/2013)... May 21, 2013 Inflamax scientists ... the ITN to design the study, which will ... key clinical models used in the study of ... Nasal Allergen Challenge (NAC) models. Although both the ... publications, to date no direct comparison between the ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3
... 23, 2010 Martek Biosciences, a company that launched ... University of Maryland, entered an agreement on December 21 ... NV for $1.1 billion, the companies jointly announced. ... is the second company sold for more than $1 ...
... Stanford University in the USA has an X-FEL (X-ray Free ... provides images of ,molecules in action, using a kilometer-long electron ... an alternative that can do many of the same things. ... half a million euro. That,s why the researchers have jokingly ...
... Md., Dec. 22, 2010 Novavax, Inc. (Nasdaq: ... Massachusetts Medical School, led by Dr. Trudy Morrison, published ... Virology, a report indicating that a novel virus-like particle ... mice from a live virus challenge.  This vaccine candidate ...
Cached Biology Technology:Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 2Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 3Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 4Eindhoven University builds affordable alternative to mega-laser X-FEL 2Eindhoven University builds affordable alternative to mega-laser X-FEL 3NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 2NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 3NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 4
(Date:5/19/2013)... Davis have engineered a strain of photosynthetic cyanobacteria to ... their findings today at the 113th General Meeting of ... we used synthetic biology approaches to probe and rewire ... for growth) cyanobacterial metabolism for the ability to grow ... on the study. He is part of Shota ...
(Date:5/18/2013)... 2013) Research presented at Digestive Disease Week ... through diet and lifestyle. , Individuals suffering ... muscle strength, fatigue and poor quality of life. ... in remission. A randomized, double blind, placebo-controlled study ... supplementation corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... provide the white noise of the South, but the night ... Southern air hangs heavy from the humidity and the sounds ... 140 species of frogs, toads and salamanders, is the center ... and swamps are the auditorium for their symphonic choruses, the ... Initiative, or ARMI, have front-row seats. , Amphibians, ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... clinical practice guideline, "Tonsillectomy in Children" will be published ... Surgery (watch for a new cover and publisher ... provides evidence-based recommendations on the pre-, intra-, and postoperative ... years under consideration for tonsillectomy. Additionally, this guideline is ...
... CORVALLIS, Ore. Members of the engineering faculty ... of radiation detection and measurement device that will be ... making the process faster, more accurate and less expensive. ... type of radiation spectrometer, and the first production of ...
... result in long waiting times for seriously ill patients. ... for the next available treatment. In this edition of ... 2010; 107[50]: 892𔃆), Michael Christ and his coauthors ... of emergency patients. Triage provides reliable methods that ...
Cached Biology News:Tonsillectomy in children 2New technology to speed cleanup of nuclear contaminated sites 2